Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.66 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.66 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.61 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.61 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.61 |
| ▸ | HTR2A | P28223 | 1/20 | 0.61 |
| ▸ | HTR2C | P28335 | 1/20 | 0.61 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.61 |
| ▸ | HRH1 | P35367 | 1/20 | 0.61 |
| ▸ | DRD3 | P35462 | 1/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1310131 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL112082 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL160269 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL112564 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL5683424 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL9118821 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL2492298 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL1457282 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL2836840 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 | |
| SCHEMBL3004163 | 1.00 | CA2 (0.71) | CA2MAPK1GRIK1GRIK2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622849-B2 | Coloration cosmetic composition with variable-color capsules | KOLMAR KOREA CO., LTD. (KR) | 2026-05-12 | — | — | US | claimed |
| EP-4137203-B1 | SKINCARE DEVICES | SEDIC FILIP (CN) | 2025-10-01 | — | — | EP | claimed |
| US-20250257281-A1 | LUBRICANT COMPOSITIONS AND METHODS OF DRY LUBRICATING SURFACE USING THE SAME | DIVERSEY, INC. (US) | 2025-08-14 | — | — | US | claimed |
| EP-3864998-B1 | MESH-TYPE MOISTURE-RELEASE CUSHION COSMETIC PRODUCT | INTERCOS KOREA INC (KR) | 2025-04-16 | — | — | EP | claimed |
| EP-4514930-A1 | LUBRICANT COMPOSITIONS AND METHODS OF DRY LUBRICATING SURFACE USING THE SAME | Diversey, Inc. (US) | 2025-03-05 | — | — | EP | claimed |
| US-20240225976-A1 | TRANSLUCENT COSMETIC COMPOSITION | AMOREPACIFIC CORPORATION (KR) | 2024-07-11 | — | — | US | claimed |
| EP-3572065-B1 | OIL-IN-WATER TYPE EMULSION COSMETIC | NIKKO CHEMICALS (JP) | 2024-05-01 | — | — | EP | claimed |
| US-20230414691-A1 | COMPOSITION INCLUDING FRACTION OF SYZYGIUM FORMOSUM EXTRACT AS ACTIVE INGREDIENT | CARBOEXPERT INC. (KR) | 2023-12-28 | — | — | US | claimed |
| WO-2023203542-A1 | LUBRICANT COMPOSITIONS AND METHODS OF DRY LUBRICATING SURFACE USING THE SAME | DIVERSEY, INC. (US) | 2023-10-26 | — | — | WO | claimed |
| WO-2023120763-A1 | EMULSION-TYPE SKIN ELASTICITY IMPROVING COSMETIC MATERIAL USING SKIN ELASTICITY COMPONENT MATERIAL OF NATURALLY-DERIVED PLANT FINGERROOT, PREPARATION METHOD THEREFOR, AND EMULSION-TYPE SKIN ELASTICITY IMPROVING COSMETICS | 이호규 | 2023-06-29 | — | — | WO | claimed |
| EP-2550955-B1 | EMULSION COMPOSITION | SHISEIDO CO LTD (JP) | 2016-12-21 | — | — | EP | claimed |
| EP-2716277-B1 | SOLID COSMETIC FOR LIPS | SHISEIDO CO LTD (JP) | 2016-02-10 | — | — | EP | claimed |
| US-9109051-B2 | Crosslinked hyaluronic acid in emulsion | EVONIK GOLDSCHMIDT GMBH (DE) | 2015-08-18 | — | — | US | claimed |
| EP-1854451-B1 | Cosmetic compositions containing block copolymers and corresponding long-wearing cosmetic product system | OREAL (FR) | 2011-04-27 | — | — | EP | claimed |
| JP-2011506719-A | — | — | 2011-03-03 | — | — | JP | claimed |
| EP-1545621-B1 | Pharmaceutical compositions comprising complexes of phosphate derivatives of lipophilic compounds | VITAL HEALTH SCIENCES PTY LTD (AU) | 2010-11-24 | — | — | EP | claimed |
| EP-1460995-B1 | TRANSDERMAL TRANSPORT OF COMPOUNDS | VITAL HEALTH SCIENCES PTY LTD (AU) | 2010-11-10 | — | — | EP | claimed |
| US-20100266512-A1 | CROSSLINKED HYALURONIC ACID IN EMULSION | EVONIK GOLDSCHMIDT GMBH (DE) | 2010-10-21 | — | — | US | claimed |
| EP-2222715-A1 | CROSSLINKED HYALURONIC ACID IN EMULSION | Evonik Goldschmidt GmbH (DE) | 2010-09-01 | — | — | EP | claimed |
| WO-2009077399-A1 | CROSSLINKED HYALURONIC ACID IN EMULSION | EVONIK GOLDSCHMIDT GMBH (DE) | 2009-06-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622849-B2 | Coloration cosmetic composition with variable-color capsules | DAGLA, LIPA, MGLL | CA2 3262/4885MAPK1 3169/4885GRIK1 3632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.